Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment
Müge Olgaça,
Corresponding author
drmugeolgac@yahoo.com.tr

Corresponding author.
, Osman Ozan Yeğitb, Şengül Beyazb, Nida Öztopb, Can Tüzerb, Deniz Eyiceb, Pelin Karadağb, Raif Coşkunc, Semra Demirb, Bahaauddin Çolakoğlub, Suna Büyüköztürkb, Aslı Gelincikb
a Division of Immunology and Allergic Diseases, Şişli Hamidiye Etfal Research and Education Hospital, Istanbul, Turkey
b Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
c Division of Immunology and Allergic Diseases, Okmeydanı Research and Education Hospital, Istanbul, Turkey
Read
2595
Times
was read the article
1026
Total PDF
1569
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 13 14 27
2024 April 154 88 242
2024 March 136 76 212
2024 February 153 84 237
2024 January 93 66 159
2023 December 87 65 152
2023 November 82 92 174
2023 October 66 86 152
2023 September 88 80 168
2023 August 60 35 95
2023 July 71 37 108
2023 June 67 50 117
2023 May 92 32 124
2023 April 89 51 140
2023 March 147 68 215
2023 February 124 51 175
2023 January 47 51 98
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.